News
Media
Conferences
Publications
CME/CE
Resources
Subscribe
About
Partnerships

|Articles|August 18, 2008

Common fibroid questions

Author(s)OBGYN.net Staff

Coverage of the 37th Annual Global Congress on Minimally Invasive Gynecology

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Related Content

FDA grants 510(k) clearance to Roche's cobas BV/CV assay

FDA grants 510(k) clearance to Roche's cobas BV/CV assay

ByJoshua Fitch, Senior Editor

July 24th 2026

A discussion of STI rates, barriers, and home screenings with Damian Alagia III, MD

A discussion of STI rates, barriers, and home screenings with Damian Alagia III, MD

ByDamian Alagia, III, MD, MS, MBA, FACS,

July 20th 2026

National strategy calls for $20B investment to close women's health gap | Image credit: stock.adobe.com

National strategy calls for $20B investment to close women's health gap

ByJoshua Fitch, Senior Editor

July 15th 2026

Kate McLean, MD, MPH, on how bacterial vaginosis subtypes may validate symptoms, guide treatment

Kate McLean, MD, MPH, on how bacterial vaginosis subtypes may validate symptoms, guide treatment

ByKate McLean MD, MPH, FACOG

July 13th 2026

At-home pelvic ultrasound feasible, preferred over in-clinic care | stock.adobe.com.

At-home pelvic ultrasound feasible, preferred over in-clinic care

ByJoshua Fitch, Senior Editor

July 7th 2026

Latest CME

SimulatEd™: A Roadmap to Personalized Care Plans and Shared Decision-Making in Low-Grade Serous Ovarian Cancer

Case-based Simulation

SimulatEd™: A Roadmap to Personalized Care Plans and Shared Decision-Making in Low-Grade Serous Ovarian Cancer

Rachel N. Grisham, MD

Trending on Contemporary OB/GYN

Telehealth expands maternal-fetal medicine access, with Jeffrey Chapa, MD

HIV screening, PrEP counseling get stronger ACOG recommendation

Updated: CMS proposed G-codes for obstetric billing draw concern from ACOG amid coding transition

Biomarker testing for preeclampsia with Lisa A. Bukovac, DO, FACOG

FDA grants 510(k) clearance to Roche's cobas BV/CV assay